Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin
Helena Branco, Júlio Oliveira, Catarina Antunes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3631-3631
Open Access | Times Cited: 20

Showing 20 citing articles:

Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment
M. Helena Vasconcelos, Andreia Palmeira, Sofia Martins Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1171-1195
Closed Access | Times Cited: 18
Discovery of Potent Isoquinolinequinone N-Oxides to Overcome Cancer Multidrug Resistance
Ryan D. Kruschel, Mélanie A. G. Barbosa, Maria João Almeida, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13909-13924
Open Access | Times Cited: 4
SLC2A1 boosts the resistance of non-small cell lung cancer to taxanes by stimulating the formation of EPCAM+ cancer stem-like cells via glycolysis
Zhe Yu, Jian Sun, Kai Fang, et al.
Translational Oncology (2024) Vol. 49, pp. 102082-102082
Open Access | Times Cited: 4
Efficacy of preoperative pulmonary rehabilitation in lung cancer patients: a systematic review and meta-analysis of randomized controlled trials
Yinglu Guo, Ming Pan, Meidi Xiong, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Special Issue: “Drug Repurposing for Cancer Therapies”
Cristina P. R. Xavier, Andreia Palmeira
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1092-1092
Open Access | Times Cited: 3
Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
Cheng-Wei Huang, Shih-Yi Lee, Chen-Xuan Du, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116298-116298
Open Access | Times Cited: 3
Nanoarchitectonics of catalytic tubular nanomotors based on Cu/Fe@SBA-15 for lung cancer treatment
Mohamed S. El-Okaily, Ahmed M. A. El‐Seidy, Eman H. Ismail, et al.
Journal of materials research/Pratt's guide to venture capital sources (2024) Vol. 39, Iss. 12, pp. 1741-1757
Open Access | Times Cited: 2
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma
Mariana Nunes, Diana Duarte, Nuno Vale, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4357-4357
Open Access | Times Cited: 11
CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model
George Perez, Mauro Rosales, Ailyn C. Ramòn, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 43-43
Open Access | Times Cited: 9
Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
Jingcheng Zhang, Ying Zhang, Ziyuan Wang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 5
Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice
Hui Li, Mei Xu, Danlei Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells
Beatriz Matos, Sara Peixoto da Silva, M. Helena Vasconcelos, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Atomoxetine suppresses radioresistance in glioblastoma via circATIC/miR-520d-5p/Notch2-Hey1 axis
Hyun Jeong Seok, Jae Yeon Choi, Dong Hyeon Lee, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer
Elena Andreucci, Kelly Bugatti, Silvia Peppicelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1475-1475
Open Access | Times Cited: 3
Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies
Ricardo G. Teixeira, János P. Mészáros, Beatriz Matos, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115922-115922
Open Access | Times Cited: 3
Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry
Francisca Carvalhal, Ana C. Magalhães, Rita Rebelo, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7204-7204
Open Access | Times Cited: 2
Unraveling the regulatory cell death pathways in pulmonary fibrosis
Jiazheng Sun, Yulan Zeng
Research Square (Research Square) (2024)
Open Access
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma
Sofia Martins Sousa, Helena Branco, Amir Avan, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 4, pp. 585-597
Open Access
Pirfenidone promotes cell cycle arrest and apoptosis of triple‑negative breast cancer cells by suppressing Hedgehog/GLI1 signaling
Shengyu Shi, Lingyu Zhao, C.F. Liu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Preclinical studies on the antitumor and non‐toxic effect of combining pirfenidone with vinorelbine and carboplatin in non‐small cell lung cancer
Helena Branco, Catarina A. Rodrigues, Júlio Oliveira, et al.
International Journal of Cancer (2024)
Open Access
Page 1

Scroll to top